What is the interpretation of low hemoglobin A (HbA) and elevated hemoglobin S (HbS) on hemoglobin electrophoresis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Low Hemoglobin A and Elevated Hemoglobin S: Interpretation

Low or absent hemoglobin A (HbA) with elevated hemoglobin S (HbS) indicates sickle cell disease, not sickle cell trait, and requires immediate referral to hematology for comprehensive disease management to prevent life-threatening complications.

Understanding the Hemoglobin Pattern

The specific percentages of HbA and HbS on hemoglobin electrophoresis determine the exact diagnosis and disease severity:

Sickle Cell Anemia (HbSS) - Most Severe

  • HbA: 0%
  • HbS: 80-95%
  • HbF: 5-15%
  • HbA2: <3-5%
  • Severe disease with hemoglobin levels typically 60-90 g/L
  • Highest risk for vaso-occlusive crises, stroke, and acute chest syndrome 1

Sickle β⁰-Thalassemia - Severe

  • HbA: 0%
  • HbS: 80-90%
  • HbF: 5-15%
  • HbA2: >3-5%
  • Clinically indistinguishable from HbSS
  • Severe phenotype with early onset painful crises 1

Sickle β⁺-Thalassemia - Mild to Moderate

  • HbA: 10-25%
  • HbS: 70-80%
  • HbF: <3%
  • HbA2: >3-5%
  • Milder clinical course than HbSS 1

Sickle-C Disease (HbSC) - Moderate

  • HbA: 0%
  • HbS: 50-55%
  • HbC: 40-45%
  • HbF: <3%
  • Higher baseline hemoglobin than HbSS
  • Moderate severity but still requires specialized care 1

Critical Distinction from Sickle Cell Trait

Sickle cell trait (HbAS) shows:

  • HbA: 55-65%
  • HbS: 30-40%
  • Benign condition with normal life expectancy
  • Only becomes clinically relevant at extremes of physiology (severe sepsis, extreme dehydration) 1

If HbA is low (<40%) or absent with elevated HbS, this is NOT trait—it is disease.

Immediate Clinical Actions Required

1. Confirm the Diagnosis

  • Verify the hemoglobin electrophoresis results show the pattern described above
  • Check complete blood count: expect chronic anemia (Hb 60-90 g/L for severe forms)
  • Look for microcytosis if β-thalassemia is co-inherited
  • Document HbF percentage: levels >8% predict milder phenotype 1

2. Assess Disease Severity

The patient requires evaluation for:

  • Chronic hemolytic anemia: baseline hemoglobin, reticulocyte count, LDH, bilirubin
  • End-organ damage: renal function, liver function, pulmonary function
  • Vascular complications: history of stroke, priapism, leg ulcers
  • Acute complications: frequency of painful crises, acute chest syndrome episodes 1

3. Urgent Referral to Hematology

All patients with sickle cell disease require specialized comprehensive care including:

  • Hydroxycarbamide therapy (raises HbF levels, reduces complications)
  • Prophylactic penicillin if functional asplenia present
  • Vaccination against encapsulated organisms
  • Regular transcranial Doppler screening in children for stroke risk
  • Pain management protocols 2

Common Pitfalls to Avoid

Do not assume this is sickle cell trait if HbS is >40-45% or if HbA is significantly reduced. The percentage matters critically for prognosis and management.

Do not delay referral even if the patient is currently asymptomatic. Sickle cell disease requires preventive care from diagnosis onward, with survival to the 7th decade possible only with optimal multidisciplinary management 1.

Do not miss co-existing conditions: Check iron status separately, as thalassemia traits may coexist and affect red cell indices 3.

Be aware of rare variants: Occasionally, other hemoglobin variants (Hb D-Punjab, Hb O-Arab, Hb E) can co-inherit with HbS and may appear similar on standard electrophoresis. If the clinical picture doesn't match the electrophoresis pattern, consider molecular genetic testing for definitive diagnosis 4.

Morbidity and Mortality Implications

Without proper management, patients with HbSS or HbSβ⁰-thalassemia face:

  • Chronic severe anemia requiring potential transfusion support
  • Recurrent vaso-occlusive painful crises
  • Stroke risk (particularly in children)
  • Acute chest syndrome (leading cause of death)
  • Progressive multi-organ damage (kidneys, lungs, heart, bones)
  • Increased surgical and perioperative complications 1

With comprehensive specialized care, including hydroxycarbamide therapy, appropriate vaccinations, and multidisciplinary management, patients can expect significantly improved quality of life and survival into the 7th decade 1.

References

3
Research

Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system.

Translational research : the journal of laboratory and clinical medicine, 2008

4
Research

Hemoglobin variant in disguise.

Clinical biochemistry, 2023

Related Questions

What is the interpretation of a hemoglobin (Hgb) electrophoresis showing Hgb A (Hemoglobin A) of 97.8%, Hgb F (Fetal Hemoglobin) of 0%, and Hgb A2 (Hemoglobin A2) of 2.2%?
How should the hemoglobin electrophoresis results showing HbA1 95%, HbA2 2.4%, elevated HbF 2.3%, and absent HbS be interpreted and what management is recommended?
What do the lab results (hemoglobin 10.2 g/dL, low mean corpuscular hemoglobin, low mean corpuscular hemoglobin concentration, platelet count 408 ×10⁹/L) indicate in a 37‑year‑old woman with a history of iron‑deficiency anemia?
In an 86-year-old woman with anemia (hemoglobin 9.7 g/dL, hematocrit 30.4 %), low red blood cell count, low MCHC, lymphopenia, normal blood urea nitrogen (BUN), low albumin/globulin (A/G) ratio, and normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT), what is the most likely diagnosis and appropriate treatment?
How should I evaluate and manage a 55-year-old man with mild anemia (hemoglobin 12.8 g/dL)?
Are there studies comparing automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD), and which modality is preferred for patients over 50 years old with chronic kidney disease?
What is the optimal anesthetic technique for a patient receiving digoxin?
How should I prescribe a medication at a dose of 2 mg to be administered every six hours?
What is the appropriate starting dose of insulin degludec (Tresiba) for a patient weighing 155.8 lb with an A1c of 12.2%?
What are the indications for using ceftibuteno (cefditoren) and which infections is it preferred for?
How should a patient with a blood pressure of 149/90 mmHg and normal renal function tests, liver function tests, and cholesterol be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.